PHAXIAM Therapeutics S.A. (PHXM) — Capital Reinvestment Ratio
Latest as of December 2012:
0.08x
PHAXIAM Therapeutics S.A. (PHXM) has a Capital Reinvestment Ratio of 0.08x as of December 2012, meaning it reinvests 0% of its operating cash flow (€621.40K) in capital expenditures (€48.40K). See how much free cash does PHAXIAM Therapeutics S.A. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
€621.40K
EUR
Capital Expenditures
€48.40K
EUR
Data as of
Dec 2012
Most recent filing
PHAXIAM Therapeutics S.A. Capital Reinvestment Ratio (2012–2012)
This chart tracks PHAXIAM Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. (2012–2012)
Year-by-year Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. from 2012 to 2012. For live market cap and broader valuation context, see market value of PHAXIAM Therapeutics S.A..
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 0.08x | €621.40K | €52.50K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow